Fragile X syndrome is the most frequent cause of intellectual disability in males, affecting 1 out of 3600 boys born. For the first time, researchers at Whitehead Institute have restored activity to the fragile X syndrome gene in affected neurons using a modified CRISPR/Cas9 system they developed that removes the methylation—the molecular tags that keep the mutant gene shut off—suggesting that this method may prove to be a useful paradigm for targeting diseases caused by abnormal methylation.
Research by the lab of Whitehead Institute Founding Member Rudolf Jaenisch, which is described online this week in the journal Cell, is the first direct evidence that removing the methylation from a specific segment within the FMR1 locus can reactivate the gene and rescue fragile X syndrome neurons.
The FMR1 gene sequence includes a series of three nucleotide (CGG) repeats, and the length of these repeats determines whether or not a person will develop fragile X syndrome: A normal version of the gene contains anywhere from 5-55 CGG repeats; versions with 56-200 repeats are considered to be at a higher risk of generating some of the syndrome’s symptoms; and those versions with more than 200 repeats will produce fragile X syndrome.
Until now, the mechanism linking the excessive repeats in FMR1 to fragile X syndrome was not well understood. But Shawn Liu, a postdoctoral researcher in Jaenisch’s lab and first author of the Cellstudy, and others thought that the methylation blanketing those nucleotide repeats might play an important role in shutting down the gene’s expression.
In order to test this hypothesis, Liu removed the methylation tags from the FMR1 repeats using a CRISPR/Cas9-based technique recently developed by him and Hao Wu, a former postdoctoral researcher in the Jaenisch lab. This technique can either add or delete methylation tags from specific stretches of DNA. Removal of the tags revived the FMR1 gene’s expression to the level of the normal gene.
“These results are quite surprising—this work produced almost a full restoration of wild type expression levels of the FMR1 gene,” says Jaenisch, who is a professor of biology at Massachusetts Institute of Technology and the senior author on the study. “Often when scientists test therapeutic interventions, they only achieve partial restoration, so these results are substantial.”
The reactivated FMR1 gene rescues neurons derived from fragile X syndrome induced pluripotent stem (iPS) cells, reversing the abnormal electrical activity associated with the syndrome. When rescued neurons were engrafted into the brains of mice, the FMR1 gene remained active in the neurons for at least three months, suggesting that the corrected methylation may be sustainable in the animal.
“We showed that this disorder is reversible at the neuron level,” says Liu. “When we removed methylation of CGG repeats in the neurons derived from fragile X syndrome iPS cells, we achieved full activation of FMR1.”
The CRISPR/Cas-9-based technique may also prove useful for other diseases caused by abnormal methylation including facioscapulohumeral muscular dystrophy and imprinting diseases.
“This work validates the approach of targeting the methylation on genes, and it will be a paradigm for scientists to follow this approach for other diseases,” says Jaenisch.
The Latest on: Fragile X syndrome
A Bar Mitzvah Tale Of Two Sons
on April 17, 2018 at 3:10 pm
In the meantime, our son Jack was diagnosed with Fragile X Syndrome and Aden was later diagnosed with Koolen deVries accompanied by a severe seizure disorder that took years to get under control. Unfortunately, the congregation was unable to help ... […]
Lysogene Reports First Quarter Financial Results and Provides Business Update
on April 16, 2018 at 3:05 am
Extended CNS pipeline with a collaboration agreement for the development of an AAV-based gene therapy for Fragile X syndrome, the most common single gene cause of autism, a condition of high unmet medical need. Completed all Investigational New Drug (IND ... […]
'Genotype-first' approach could fine-tune diagnosis of genetic disorders
on April 13, 2018 at 1:41 pm
much like what has been done with Fragile X syndrome," he said, referring to progress that has been made in that disease by performing extensive examinations of mutations in the FMR1 gene. FMR1 codes for a protein called FMRP, which helps regulate the ... […]
Fragile X checklist; France plays catch-up; bar-coded neurons and more
on April 13, 2018 at 5:43 am
Children diagnosed with autism are typically referred for tests of fragile X syndrome, the genetic condition most commonly associated with autism. In low-resource settings, however, the tests aren’t always feasible. A study published 6 April in ... […]
Newly identified gene mutation results in intellectual disability and developmental delay
on April 12, 2018 at 1:31 pm
much like what has been done with Fragile X syndrome," he says, citing the progress in understanding Fragile X based on extensive examinations of mutations in the FMRP gene associated with that disease. Funding: U.S. National Human Genome Research ... […]
UC Davis MIND Institute hosts open house
on April 7, 2018 at 5:04 pm
Neurodevelopmental disorders such as Down’s and fragile x syndrome — which contribute to delays in development, learning and social challenges — were added to the list. On Saturday, the institute celebrated its 20-year anniversary with an open house. […]
Rise Of New CRISPR Inventions: The Toolbox Of Research Applications For CRISPR-Based Systems Continues To Expand
on April 6, 2018 at 4:25 am
which is silenced in Fragile X Syndrome (the most common genetic form of intellectual disability in males). Hypermethylation of CGG repeats in that region is thought to be associated with the silencing of the gene. Through this targeted demethylation ... […]
Fragile X Syndrome Market Pipeline Review, H1 2018
on April 6, 2018 at 3:17 am
Fragile X syndrome is a genetic condition that causes a range of developmental problems including learning disabilities and cognitive impairment. Fragile X syndrome is caused by a change in a gene called FMR1. Fragile X syndrome occurs both in male and female. […]
Fragile X imaging study reveals differences in infant brains
on April 4, 2018 at 8:07 am
CHAPEL HILL, NC - For the first time, UNC School of Medicine researchers have used MRIs to show that babies with the neurodevelopmental condition fragile X syndrome had less-developed white matter compared to infants that did not develop the condition. […]
via Google News and Bing News